| DC Field | Value | Language |
|---|
| dc.contributor.author | T.Sh. Abdikadirova., A.V. Alieva., R.H. Trigulova., H.K. Nasirova | - |
| dc.date.accessioned | 2026-09-16T11:46:57Z | - |
| dc.date.available | 2026-09-16T11:46:57Z | - |
| dc.date.issued | 2026-05-11 | - |
| dc.identifier.uri | http://repo.tma.uz/xmlui/handle/1/5216 | - |
| dc.description.abstract | The use of amiodarone in the treatment of cardiac
arrhythmias is associated with a significant risk of thyroid
dysfunction, particularly in patients living in iodine- deficient regions [1,2,6]. Excess iodine load, combined
with compensatory instability of the thyroid gland, may
lead to the development of thyrotoxicosis [1,5,6], which
adversely affects the course of cardiovascular diseases and
worsens prognosis. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | Germaniya (INTERNATIONAL CONFERENCE ON HEALTH & TECHNOLOGY) journal | en_US |
| dc.subject | amiodarone, thyroid dysfunction, thyrotoxicosis, heart rate variability, iodine deficiency, arrhythmias | en_US |
| dc.title | THYROID DYSFUNCTION ASSOCIATED WITH ANTIARRHYTHMIC THERAPY IN PATIENTS FROM IODINE-DEFICIENT REGIONS OF THE ARAL SEA AREA | en_US |
| dc.type | Article | en_US |
| Appears in Collections: |
|
